Acumen Pharmaceuticals (ACOG) – BullishDoctor
Pitch Summary: @NeuroStockDoc pitches ACOG as a tolerability-focused Alzheimer’s drug launch story centered on ZUNVEYL, a prodrug of galantamine designed to reduce GI and insomnia issues. The drug targets LTC settings where AD prevalence is extremely high and half of patients cannot tolerate existing meds. Survey data shows strong physician intent to prescribe, and the […]
